» Articles » PMID: 34694427

Endocardial Left Ventricular Pacing

Overview
Journal Herz
Date 2021 Oct 25
PMID 34694427
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiac resynchronization therapy (CRT) is an effective treatment for dyssynchronous heart failure; however, 30-50% of patients fail to improve after implant. Endocardial left ventricular (LV) pacing is an alternative therapy for patients who do not respond to conventional CRT or in whom placement of a lead via the coronary sinus is not possible. It enables pacing at a wide variety of sites, without restrictions due to coronary sinus anatomy, and there is evidence of superior electrical resynchronization and hemodynamic response compared with conventional epicardial CRT. In this article, we discuss the potential advantages and disadvantages of endocardial LV pacing compared with conventional CRT, review the evidence for the delivery of endocardial LV pacing using both lead-based and leadless systems, and explore possible future directions of this novel technology.

Citing Articles

Observational Study of Trans-Septal Endocardial Left Ventricle Lead Implant for Effective Cardiac Resynchronization Therapy in Patients with Heart Failure and Challenging Coronary Sinus Anatomy.

Farhangee A, Davies M, Gaughan K, Mesina M, Mindrila I Biomedicines. 2025; 12(12.

PMID: 39767600 PMC: 11673049. DOI: 10.3390/biomedicines12122693.

References
1.
Chung E, Leon A, Tavazzi L, Sun J, Nihoyannopoulos P, Merlino J . Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008; 117(20):2608-16. DOI: 10.1161/CIRCULATIONAHA.107.743120. View

2.
Leon A, Abraham W, Curtis A, Daubert J, Fisher W, Gurley J . Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. J Am Coll Cardiol. 2005; 46(12):2348-56. DOI: 10.1016/j.jacc.2005.08.031. View

3.
Elencwajg B, Lopez-Cabanillas N, Fischer A, Negrete A, Marin J, Delgado L . Multicenter prospective observational long-term follow-up study of endocardial cardiac resynchronization therapy using the Jurdham procedure. Heart Rhythm. 2019; 16(10):1453-1461. DOI: 10.1016/j.hrthm.2019.07.017. View

4.
Carabelli A, Jabeur M, Jacon P, Rinaldi C, Leclercq C, Rovaris G . European experience with a first totally leadless cardiac resynchronization therapy pacemaker system. Europace. 2020; 23(5):740-747. PMC: 8139811. DOI: 10.1093/europace/euaa342. View

5.
Behar J, Bostock J, Li A, Chin H, Jubb S, Lent E . Cardiac Resynchronization Therapy Delivered Via a Multipolar Left Ventricular Lead is Associated with Reduced Mortality and Elimination of Phrenic Nerve Stimulation: Long-Term Follow-Up from a Multicenter Registry. J Cardiovasc Electrophysiol. 2015; 26(5):540-6. PMC: 4864396. DOI: 10.1111/jce.12625. View